ID

20388

Descrizione

The purpose of the trial is to determine if extended-release dipyridamole + aspirin [Aggrenox, Asasa ntin] is superior to clopidogrel [Plavix], and if telmisartan [Micardis, Gliosartan, Kinzal, Kinzalm ono, Predxal, Pritor, Samertan, Telmisartan] is superior to placebo, in the presence of background antihypertensive therapy, in prevention of a second stroke in patients who have recently suffered a stroke and therefore are at high risk of suffering another one. End of Trial Study Source & Descriptions: https://clinicaltrials.gov/ct2/show/NCT00153062?term=NCT00153062&rank=1

collegamento

https://clinicaltrials.gov/ct2/show/NCT00153062?term=NCT00153062&rank=1

Keywords

versioni (1)
  1. 21/02/17 21/02/17 -
Caricato su

21 febbraio 2017

DOI

Per favore, per richiedere un accesso.

Licenza

Creative Commons BY 4.0
Commenti del modello :

Puoi commentare il modello dati qui. Tramite i fumetti nei gruppi di articoli e articoli è possibile aggiungere commenti a quelli in modo specifico.

Torna ai commenti del modello
Commenti del gruppo di articoli per :

Commenti dell'articolo per :

  • i più nuovi
  • i più vecchi
  • Popolare
  • i più nuovi
    • i più nuovi
    • i più vecchi
    • Popolare

Non ci sono commenti

Per scaricare i modelli di dati devi essere registrato. Per favore accesso o registrati GRATIS.

End of Trial Concomitant Medication ACE Inhibitors PRoFESS - Prevention Regimen For Effectively Avoiding Second Strokes NCT00153062

Inglese

End of Trial Concomitant Medication ACE Inhibitors PRoFESS - Prevention Regimen For Effectively Avoiding Second Strokes NCT00153062

1 moduli  
Concomitant Medication
Descrizione

Concomitant Medication

Alias
UMLS CUI-1
C2347852
1. Since the visit 5, were any of the non-study medications listed below taken?
Descrizione

Medication taken

Tipo di dati

boolean

Alias
UMLS CUI [1]
C1553892
If yes, please indicate which of the following were being taken:
Descrizione

If yes, please indicate which

Tipo di dati

integer

Alias
UMLS CUI [1]
C1553892
ACE Inhibitors
Descrizione

ACE Inhibitors

Alias
UMLS CUI-1
C0003015
2. Since the visit 5, were any ACE inhibitors taken?
Descrizione

ACE Inhibitors currently taken

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0013227
If Yes, please indicate which, and total daily dose:
Descrizione

Name of ACE Inhibitor and Total Daily Dose

Tipo di dati

text

Alias
UMLS CUI [1,1]
C0003015
UMLS CUI [1,2]
C2360065
UMLS CUI [2,1]
C0003015
UMLS CUI [2,2]
C2348070
Restricted Concomitant Medication
Descrizione

Restricted Concomitant Medication

Alias
UMLS CUI-1
C2347852
UMLS CUI-2
C0233470
3. Have any restricted medications in the categories defined on the opposite page been taken?
Descrizione

Restricted medication taken

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C1518384
UMLS CUI [1,2]
C0087111
If yes, please indicate which category
Descrizione

if yes

Tipo di dati

integer

Alias
UMLS CUI [1]
C0683312
Ritorna all'inizio della pagina

Similar models

End of Trial Concomitant Medication ACE Inhibitors PRoFESS - Prevention Regimen For Effectively Avoiding Second Strokes NCT00153062

1 moduli
Name
genere
Description | Question | Decode (Coded Value)
Tipo di dati
Alias
Item Group
Concomitant Medication
C2347852 (UMLS CUI-1)
Medication taken
Item
1. Since the visit 5, were any of the non-study medications listed below taken?
boolean
C1553892 (UMLS CUI [1])
Item
If yes, please indicate which of the following were being taken:
integer
C1553892 (UMLS CUI [1])
If yes, please indicate which
Code List
If yes, please indicate which of the following were being taken:
CL Item
Parental anticoagulants (Short term use) (1)
CL Item
Oral anticoagulants (Short term use) (2)
CL Item
Nitrates (oral or topical) (3)
CL Item
Estrogen replacement without progesterone (4)
CL Item
Estrogen replacement with progesterone (5)
CL Item
Digitalis (6)
CL Item
Statins (7)
CL Item
Fibrates (8)
CL Item
Dilitazem/Verapamil (9)
CL Item
Other calcium channel blockers (10)
CL Item
Alpha-blocker (11)
CL Item
Direct vasodilators (12)
CL Item
Peripheral sympatholytic (13)
CL Item
Central sympatholytic (14)
CL Item
Alpha-beta blocker (15)
CL Item
Beta-blocker (16)
CL Item
Loop-active diuretics (17)
CL Item
Diuretics of thiazide type (18)
CL Item
Potassium-sparing diuretics (19)
CL Item
Insulin (20)
CL Item
Oral hypoglycemic agents (21)
CL Item
Specific Cox II inhibitors (22)
Item Group
ACE Inhibitors
C0003015 (UMLS CUI-1)
ACE Inhibitors currently taken
Item
2. Since the visit 5, were any ACE inhibitors taken?
boolean
C0013227 (UMLS CUI [1])
Name of ACE Inhibitor and Total Daily Dose
Item
If Yes, please indicate which, and total daily dose:
text
C0003015 (UMLS CUI [1,1])
C2360065 (UMLS CUI [1,2])
C0003015 (UMLS CUI [2,1])
C2348070 (UMLS CUI [2,2])
Item Group
Restricted Concomitant Medication
C2347852 (UMLS CUI-1)
C0233470 (UMLS CUI-2)
Restricted medication taken
Item
3. Have any restricted medications in the categories defined on the opposite page been taken?
boolean
C1518384 (UMLS CUI [1,1])
C0087111 (UMLS CUI [1,2])
Item
If yes, please indicate which category
integer
C0683312 (UMLS CUI [1])
if yes
Code List
If yes, please indicate which category
CL Item
1 (1)
CL Item
2 (2)
CL Item
3 (3)
CL Item
4 (4)
CL Item
5 (5)
CL Item
6 (6)
CL Item
7 (7)
Ritorna all'inizio della pagina 

Aiuto

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial